Brain Concussion
A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)
Subtype terms (2)
More specific conditions that are subtypes of Brain Concussion in the MeSH hierarchy.
- Contrecoup Injury
- Post-Concussion Syndrome
14 drugs (11 approved, 3 experimental)
Drugs by status
Phase 4 trials (2)
Phase 3 trials (6)
Phase 2 trials (13)
Phase 1 trials (10)
Organizations
Organization Involved with Phase 4 Indications (1)
Organization Involved with Phase 3 Indications (3)
Organization Involved with Phase 2 Indications (19)
- Amgen
- Novo Nordisk
- Novartis
- Neuren Pharmaceuticals Limited
- The Dana Foundation
- University of Pennsylvania
- University of Arizona
- Baylor University
- Chang Gung University
- Main Line Health
- Northwestern University
- University of Kansas
- University of Michigan
- University of Copenhagen
- Detroit Receiving Hospital
- University of Texas at Houston
- Department of Veteran Affairs
- The University of Texas, Dallas
- Center for Neurological Studies (CNS)
Organization Involved with Phase 1 Indications (6)
Organization Involved with Other Experimental Indications (9)